Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Successful Treatment of Refractory CMV Chorioretinitis and Meningoencephalitis with Adoptive Transfer of Third Party CMVpp65 Specific T-Cell Lines

Susan Prockop, MD, Aisha Hasan, MD, Ekaterina Doubrovina, MD PhD, H.R. Castro-Malaspina, MD, Juliet N. Barker, MBBS(Hons), FRACP, Parastoo B Dahi, MD, Farid Boulad, MD, Nancy A. Kernan, MD, Guenther Koehne, MD PhD, Craig S. Sauter, MD, Szilard Kiss, MD, Mrinali Patel, MD, Stephanie Suser, BA, Richard J O'Reilly, MD

Blood (2015) 126 (23): 3157.

https://doi.org/10.1182/blood.V126.23.3157.3157

Published: 2015

Journal Articles

A Prospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/ Refractory Hodgkin Lymphoma

Miguel-Angel Perales, MD, Christina Cho, MD, Anne Eaton, MS, Alison J Moskowitz, MD, Victoria Nguyen, BS, Anne Marie R. Gonzales-Dadiz, BS, Sean Devlin, PhD, Sergio A. Giralt, MD, Ann A. Jakubowski, MD PhD, Matthew J. Matasar, MD MS, Ariela Noy, MD, Carol S. Portlock, MD, David J. Straus, MD, James W. Young, MD, Juliet N. Barker, MBBS(Hons), FRACP, Craig H. Moskowitz, MD

Blood (2015) 126 (23): 4383.

https://doi.org/10.1182/blood.V126.23.4383.4383

Published: 2015

Journal Articles

Successful Treatment of Peripheral T-Cell Lymphoma with Allogeneic Stem Cell Transplantation: A Large Single-Center Experience

Neha Mehta-Shah, MD, Joanne Chou, Molly Maloy, MS, Zhigang Zhang, PhD, Alison J. Moskowitz, MD, Craig H Moskowitz, MD, Juliet N. Barker, MBBS(Hons), FRACP, Sergio Giralt, MD, Miguel-Angel Perales, MD, Steven M Horwitz, MD, Craig S. Sauter, MD, Parastoo B. Dahi, MD

Blood (2015) 126 (23): 4392.

https://doi.org/10.1182/blood.V126.23.4392.4392

Published: 2015

Journal Articles

Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical CD34+ Selected Peripheral Blood Stem Cells (PBSC) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection and Frequent Pre-Engraftment Syndrome

Blood (2014) 124 (21): 3903.

https://doi.org/10.1182/blood.V124.21.3903.3903

Published: 2014

Journal Articles

Day 45 Lymphocyte Recovery Is Independently Associated with Transplant-Related Mortality after Adult Myeloablative Double-Unit Cord Blood Transplantation (dCBT)

Duncan Purtill, FRACP,FRCPA,MBBS, Doris M. Ponce, MD, Sean M. Devlin, PhD, Marissa N Lubin, BA, Parastoo B Dahi, MD, Sergio A Giralt, MD, Miguel-Angel Perales, MD, Richard J. O'Reilly, MD, Marcel R.M. van den Brink, MD PhD, James W. Young, MD, Andromachi Scaradavou, MD, Cladd Stevens, MD, Juliet N. Barker, MBBS(Hons), FRACP

Blood (2014) 124 (21): 1156.

https://doi.org/10.1182/blood.V124.21.1156.1156

Published: 2014

Journal Articles

Quantitative Assessment of T Cell Repertoire Recovery after Double Unit Cord Blood Transplantation Demonstrates Early T Cell Diversity and Correlation Between CMV Reactivation and CD8 Clonal Domimance

Miguel Perales, MD, Ying Taur, MD, Ingrid Leiner, MS, Marissa N Lubin, BA, Boze Susac, BA, Eric G. Pamer, MD, Juliet N. Barker, MBBS(Hons), FRACP

Blood (2014) 124 (21): 1158.

https://doi.org/10.1182/blood.V124.21.1158.1158

Published: 2014

Journal Articles

Successful Salvage of High-Risk B-Cell Non-Hodgkin and Hodgkin Lymphoma with Double-Unit Cord Blood Transplantation Provides a Platform for Further Optimization

Parastoo B Dahi, MD, Craig S. Sauter, MD, Sean M. Devlin, PhD, Marissa N Lubin, BA, Doris M. Ponce, MD, Sergio Giralt, MD, Guenther Koehne, MD PhD, Miguel-Angel Perales, MD, Andrew D. Zelenetz, MD PhD, Craig H. Moskowitz, MD, Juliet N. Barker, MBBS(Hons), FRACP

Blood (2014) 124 (21): 1258.

https://doi.org/10.1182/blood.V124.21.1258.1258

Published: 2014

Journal Articles

Comparable 3-Year Disease-Free Survival Regardless of Anti-Thymocyte Globulin Inclusion in Pediatric Myeloablative Cord Blood Transplantation for Acute Lymphoblastic Leukemia

Doris M. Ponce, MD, Rodney Sparapani, PhD, Junfang Chen, MS, Vanderson Rocha, MD PhD, Daniel H. Fowler, MD, Mary Eapen, MBBS, Juliet N. Barker, MBBS(Hons), FRACP, Miguel-Angel Perales, MD

Blood (2014) 124 (21): 1259.

https://doi.org/10.1182/blood.V124.21.1259.1259

Published: 2014

Journal Articles

Autoimmune Hemolysis & Immune Thrombocytopenic Purpura after Cord Blood Transplantation (CBT) May be Life-Threatening & Warrants Early Therapy with Rituximab

Valkal Bhatt, PharmD, Leyla Shune, MD, Emily J Lauer, BS, BA, Marissa N Lubin, BA, Sean M. Devlin, PhD, Andromachi Scaradavou, MD, Nancy A. Kernan, MD, Sergio Giralt, MD, Rekha Parameswaran, MD, Miguel-Angel Perales, MD, Doris M. Ponce, MD, Gerald A. Soff, MD, Juliet N. Barker, MBBS(Hons), FRACP

Blood (2014) 124 (21): 1142.

https://doi.org/10.1182/blood.V124.21.1142.1142

Published: 2014

Journal Articles

Allogeneic Transplantation for Chronic Myelomonocytic Leukemia (CMML) Is Associated with High Disease-Free Survival Even in the Setting of High-Risk Disease

Matias Eugenio Sanchez, MD, Kamal Kant Singh Abbi, MBBS, Roni Tamari, MD, Ann Jakubowsky, MD PhD, Esperanza B Papadopoulos, MD, Sean M. Devlin, PhD, Weiji Shi, MS, Craig S. Sauter, MD, Juliet N. Barker, MBBS(Hons), FRACP, Farid Boulad, MD, Sergio Giralt, MD, Richard Meagher, MD, Hugo Castro-Malaspina, MD

Blood (2014) 124 (21): 2575.

https://doi.org/10.1182/blood.V124.21.2575.2575

Published: 2014

Journal Articles

Myeloablative Double-Unit Cord Blood Transplantation (CBT) in Pediatric Patients with High-Risk Acute Leukemia Demonstrates Encouraging Disease-Free Survival with Both TBI and Chemotherapy-Only-Based Conditioning

Andromachi Scaradavou, MD, Marissa N Lubin, BA, Patrick Hilden, MS, Farid Boulad, MD, Kevin J. Curran, MD, Rachel Kobos, MD, Susan E. Prockop, MD, Richard J. O'Reilly, MD, Jo-Ann Tonon, Courtney Byam, BS, Peter G Steinherz, MD, Neerav Shukla, MD, Aisha Hasan, MD, Thomas M. Renaud, MD, Nicole Zakak, N.P., Nancy A. Kernan, MD, Juliet N. Barker, MBBS(Hons), FRACP

Blood (2014) 124 (21): 2578.

https://doi.org/10.1182/blood.V124.21.2578.2578

Published: 2014

Journal Articles

Analysis of 129 Myeloablative Double-Unit Cord Blood Transplantation Recipients Demonstrates an Independent Association Between Non-Dominant Unit TNC Dose and Engraftment Suggesting a Facilitation Effect

Duncan Purtill, FRACP,FRCPA,MBBS, Marissa N Lubin, BA, Doris M. Ponce, MD, Sergio Giralt, MD, Miguel-Angel Perales, MD, Richard J O'Reilly, MD, Marcel Van Den Brink, MD PhD, James W. Young, MD, Andromachi Scaradavou, MD, Cladd Stevens, MD, Juliet N. Barker, MBBS(Hons), FRACP

Blood (2014) 124 (21): 2459.

https://doi.org/10.1182/blood.V124.21.2459.2459

Published: 2014

Journal Articles

Disease-Free Survival in Adult Patients with Acute Leukemia and Advanced CML Supports Use of Double-Unit Cord Blood Grafts As an Immediate Alternative to 8/8 HLA-Matched Unrelated Donors (URD)

Doris M. Ponce, MD, Patrick Hilden, MS, Sean M. Devlin, PhD, Molly Maloy, MA, Marissa N Lubin, BA, H.R. Castro-Malaspina, MD, Jenna D Goldberg, MD, Ann A. Jakubowski, MD PhD, Richard Meagher, PhD, Esperanza B Papadopoulos, MD, Miguel-Angel Perales, MD, Craig S. Sauter, MD, Marcel R.M. van den Brink, MD PhD, James W. Young, MD, Nancy A. Kernan, MD, Richard J O'Reilly, MD, Andromachi Scaradavou, MD, Sergio Giralt, MD, Juliet N. Barker, MBBS(Hons), FRACP

Blood (2014) 124 (21): 2588.

https://doi.org/10.1182/blood.V124.21.2588.2588

Published: 2014

Journal Articles

T-Cell Depleted (TCD) Hematopoietic Stem Cell Transplantation (HCT) For Adult Patients With Acute Myelogenous Leukemia (AML) In First and Second Remission: Long-Term Disease Free Survival(DFS) With a Significantly Reduced Risk Of Graft-Versus-Host Disease(GvHD)

Izaskun Ceberio, MD, Patrick Hilden, MS, Sean M. Devlin, PhD, Molly Maloy, MA, Jenna D Goldberg, MD, Miguel A Perales, MD, Juliet N Barker, MBBS, (Hons), FRACP, Hugo Castro-Malaspina, MD, Guenther Koehne, MD, PhD, Doris M Ponce, MD, Craig S. Sauter, MD, Marcel R.M. van den Brink, MD, PhD, James W. Young, MD, Richard J. O'Reilly, MD, Sergio Giralt, MD, Ann A. Jakubowski, MD, PhD, Esperanza B Papadopoulos, M.D.

Blood (2013) 122 (21): 3387.

https://doi.org/10.1182/blood.V122.21.3387.3387

Published: 2013

Journal Articles

Higher Mycophenolic Acid (MPA) Trough Levels Result In Lower Day 100 Severe Acute GVHD Without Increased Toxicity In Double-Unit Cord Blood Transplantation (CBT) Recipients

Stephen J. Harnicar, PharmD, BCOP, BCPS, Doris M Ponce, MD, David Gregornik, PharmD, Sherry Mathew, PharmD, BCOP, Katherine L Evans, BA, Junting Zheng, MS, Sean Devlin, PhD, Melissa Pozotrigo, PharmD, BCOP, Andromachi Scaradavou, MD, Nancy A. Kernan, MD, Nelly G. Adel, PharmD, BCOP, BCPS, Juliet N Barker, MBBS, (Hons), FRACP

Blood (2013) 122 (21): 3297.

https://doi.org/10.1182/blood.V122.21.3297.3297

Published: 2013

Journal Articles

High Day 28 ST2 Biomarker Levels Predict Severe Day 100 Acute Graft-Versus-Host Disease and Day 180 Transplant-Related Mortality After Double-Unit Cord Blood Transplantation

Doris M Ponce, MD, Patrick Hilden, MS, Christy Mumaw, MS, Sean Devlin, PhD, Marissa N Lubin, BA, Katherine L Evans, BA, Susan Prockop, MD, Andromachi Scaradavou, MD, Nancy A. Kernan, MD, Sergio A Giralt, MD, Marcel R.M. van den Brink, MD, PhD, Sophie Paczesny, MD, PhD, Juliet N Barker, MBBS, (Hons), FRACP

Blood (2013) 122 (21): 146.

https://doi.org/10.1182/blood.V122.21.146.146

Published: 2013

Journal Articles

Prospective Evaluation Of Alternative Donor Availability In 708 Patients: Improved Allograft Access With Enlarging CB Inventory For All Patients Including Racial and Ethnic Minorities

Parastoo B. Dahi, MD, Doris M. Ponce, MD, Courtney Byam, BS, Sean Devlin, PhD, Marissa N. Lubin, BA, Katherine L. Evans, BA, Anne Marie R. Gonzales, BS, Melissa Sideroff, BA, Deborah Wells, MA, Sergio A. Giralt, MD, James W. Young, MD, Esperanza B. Papadopoulos, MD, Nancy A. Kernan, MD, Andromachi Scaradavou, MD, Juliet N. Barker, MBBS, (Hons), FRACP

Blood (2013) 122 (21): 162.

https://doi.org/10.1182/blood.V122.21.162.162

Published: 2013

Journal Articles

The Hematopoietic Cell Transplant-Co-Morbidity Index (HCT-CI) Predicts Outcomes After T Cell Depleted (TCD) Allogeneic HCT For AML and MDS

Ravin Ratan, MD, Izaskun Ceberio, MD, Patrick Hilden, MS, Sean M. Devlin, PhD, Molly A Malloy, Juliet N Barker, MBBS, (Hons), FRACP, Hugo Castro-Malaspina, MD, Ann A. Jakubowski, MD, PhD, Guenther Koehne, MD, PhD, Esperanza B Papadopoulos, MD, Doris M Ponce, MD, Craig S. Sauter, MD, Marcel R.M. van den Brink, MD, PhD, James W. Young, MD, Richard J. O'Reilly, MD, Sergio Giralt, MD, Jenna D Goldberg, MD, Miguel-Angel Perales, MD

Blood (2013) 122 (21): 2045.

https://doi.org/10.1182/blood.V122.21.2045.2045

Published: 2013

Journal Articles

Intensified Mycophenolate Mofetil (MMF) Dosing Every 8 Hours Is Safe From The Standpoint Of Engraftment and May Ameliorate Severe Acute Graft-Versus-Host Disease (GVHD) After Double-Unit Cord Blood Transplantation (CBT)

Doris M Ponce, MD, Stephen J. Harnicar, PharmD, BCOP, BCPS, Sean Devlin, PhD, Patrick Hilden, MS, Katherine L Evans, BA, Marissa N Lubin, BA, Sergio A Giralt, MD, Jenna D Goldberg, MD, Miguel-Angel Perales, MD, Nancy A. Kernan, MD, Susan E. Prockop, MD, Andromachi Scaradavou, MD, Juliet N Barker, MBBS, (Hons), FRACP

Blood (2013) 122 (21): 4600.

https://doi.org/10.1182/blood.V122.21.4600.4600

Published: 2013

Journal Articles

Double-Unit Cord Blood (CB) Transplantation Combined With Haplo-Identical CD34+ Cell-Selected PBSC Results In 100% CB Engraftment With Enhanced Myeloid Recovery

Juliet N Barker, MBBS, (Hons), FRACP, Doris M Ponce, MD, Parastoo B Dahi, MD, Sean Devlin, PhD, Katherine L Evans, BA, Marissa N Lubin, BA, Richard Meagher, PhD, Lilian Reich, MD, Hugo Castro-Malaspina, MD, Jenna D Goldberg, MD, Ann A. Jakubowski, MD, PhD, Guenther Koehne, MD, PhD, Esperanza B Papadopoulos, M.D., Miguel-Angel Perales, MD, Craig S. Sauter, MD, Andromachi Scaradavou, MD, Nancy A. Kernan, MD, Sergio A Giralt, MD, Richard J. O'Reilly, MD

Blood (2013) 122 (21): 298.

https://doi.org/10.1182/blood.V122.21.298.298

Published: 2013

NARROW

Successful Treatment of Refractory CMV Chorioretinitis and Meningoencephalitis with Adoptive Transfer of Third Party CMVpp65 Specific T-Cell Lines

A Prospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/ Refractory Hodgkin Lymphoma

Successful Treatment of Peripheral T-Cell Lymphoma with Allogeneic Stem Cell Transplantation: A Large Single-Center Experience

Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical CD34+ Selected Peripheral Blood Stem Cells (PBSC) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection and Frequent Pre-Engraftment Syndrome

Day 45 Lymphocyte Recovery Is Independently Associated with Transplant-Related Mortality after Adult Myeloablative Double-Unit Cord Blood Transplantation (dCBT)

Quantitative Assessment of T Cell Repertoire Recovery after Double Unit Cord Blood Transplantation Demonstrates Early T Cell Diversity and Correlation Between CMV Reactivation and CD8 Clonal Domimance

Successful Salvage of High-Risk B-Cell Non-Hodgkin and Hodgkin Lymphoma with Double-Unit Cord Blood Transplantation Provides a Platform for Further Optimization

Comparable 3-Year Disease-Free Survival Regardless of Anti-Thymocyte Globulin Inclusion in Pediatric Myeloablative Cord Blood Transplantation for Acute Lymphoblastic Leukemia

Autoimmune Hemolysis & Immune Thrombocytopenic Purpura after Cord Blood Transplantation (CBT) May be Life-Threatening & Warrants Early Therapy with Rituximab

Allogeneic Transplantation for Chronic Myelomonocytic Leukemia (CMML) Is Associated with High Disease-Free Survival Even in the Setting of High-Risk Disease

Myeloablative Double-Unit Cord Blood Transplantation (CBT) in Pediatric Patients with High-Risk Acute Leukemia Demonstrates Encouraging Disease-Free Survival with Both TBI and Chemotherapy-Only-Based Conditioning

Analysis of 129 Myeloablative Double-Unit Cord Blood Transplantation Recipients Demonstrates an Independent Association Between Non-Dominant Unit TNC Dose and Engraftment Suggesting a Facilitation Effect

Disease-Free Survival in Adult Patients with Acute Leukemia and Advanced CML Supports Use of Double-Unit Cord Blood Grafts As an Immediate Alternative to 8/8 HLA-Matched Unrelated Donors (URD)

T-Cell Depleted (TCD) Hematopoietic Stem Cell Transplantation (HCT) For Adult Patients With Acute Myelogenous Leukemia (AML) In First and Second Remission: Long-Term Disease Free Survival(DFS) With a Significantly Reduced Risk Of Graft-Versus-Host Disease(GvHD)

Higher Mycophenolic Acid (MPA) Trough Levels Result In Lower Day 100 Severe Acute GVHD Without Increased Toxicity In Double-Unit Cord Blood Transplantation (CBT) Recipients

High Day 28 ST2 Biomarker Levels Predict Severe Day 100 Acute Graft-Versus-Host Disease and Day 180 Transplant-Related Mortality After Double-Unit Cord Blood Transplantation

Prospective Evaluation Of Alternative Donor Availability In 708 Patients: Improved Allograft Access With Enlarging CB Inventory For All Patients Including Racial and Ethnic Minorities

The Hematopoietic Cell Transplant-Co-Morbidity Index (HCT-CI) Predicts Outcomes After T Cell Depleted (TCD) Allogeneic HCT For AML and MDS

Intensified Mycophenolate Mofetil (MMF) Dosing Every 8 Hours Is Safe From The Standpoint Of Engraftment and May Ameliorate Severe Acute Graft-Versus-Host Disease (GVHD) After Double-Unit Cord Blood Transplantation (CBT)

Double-Unit Cord Blood (CB) Transplantation Combined With Haplo-Identical CD34+ Cell-Selected PBSC Results In 100% CB Engraftment With Enhanced Myeloid Recovery

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only